Physician profile
David Gay
NPI 1356402390
$5,484.75
in general payments reported to CMS, 2019-2025
23 companies · $249 in 2025
The $249 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $205 · 2020: $226 · 2021: $1,398 · 2022: $1,839 · 2023: $1,540 · 2024: $27.32 · 2025: $249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $940 · Travel and Lodging: $812 · Consulting Fee: $65.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $939.59 |
| Travel and Lodging | $811.68 |
| Consulting Fee | $65.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exactech, INC. | $2,979.47 | 2022-2023 | |
| Team 1, LLC | $697.22 | 2021 | |
| Arthrex, INC. | $551.95 | 2021-2023 | Arthrex |
| Endo Pharmaceuticals INC. | $374.78 | 2019-2023 | Xiaflex |
| Smith+Nephew, INC. | $139.24 | 2020-2025 | Pico 14, Renasys Touch |
| Stryker Corporation | $108.19 | 2019-2023 | Mako |
| Endo USA, INC. | $89.92 | 2025 | Xiaflex |
| Abbott Laboratories | $68.24 | 2021 | |
| Carbofix Orthopedics INC | $65.00 | 2023 | |
| Highridge Medical LLC | $62.26 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Ebi, LLC | $62.26 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Pacira Therapeutics, INC. | $60.38 | 2020-2021 | |
| Vericel Corporation | $35.30 | 2021-2022 | |
| Linvatec Corporation | $27.32 | 2024 | Biobrace 23mm |
| Heron Therapeutics, INC. | $24.26 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Checkpoint Surgical, INC | $20.64 | 2022 | |
| Bioventus LLC | $19.75 | 2023 | Durolane |
| Djo, LLC | $17.67 | 2019 | |
| Depuy Synthes Sales INC. | $17.27 | 2021 | |
| Kci USA, INC. | $16.38 | 2020 | |
| Axogen | $16.07 | 2023 | Avance Nerve Graft |
| Zimmer Biomet Holdings, INC. | $15.76 | 2023 | Mymobility Platform |
| Innovation Technologies INC | $15.42 | 2025 | Irrisept |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Gay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.